Strong Revenue and Earnings Performance
Cigna Group delivered revenue of $69.7 billion and adjusted earnings of $7.83 per share in Q3 2025, reaffirming its full-year EPS outlook of at least $29.60.
Investment and Strategic Actions
Completed a strategic investment in Shields Health Solutions to enhance specialty capabilities. Also announced a new rebate-free pharmacy benefits model.
Specialty & Care Services Growth
Specialty & Care Services delivered 11% adjusted earnings growth, reflecting strong specialty volume growth and increased biosimilar adoption.
Client Retention and Renewals
Achieved approximately 97% retention in the Pharmacy Benefit Services business, with proactive renewals and extensions with major clients including the U.S. Department of Defense, Prime Therapeutics, and Centene.